Global NGS-based RNA-sequencing Market Insights, Forecast to 2028

TABLE OF CONTENTS

1 Report Business Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global NGS-based RNA-sequencing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 Sequencing by Synthesis
  • 1.2.3 Ion Semiconductor Sequencing
  • 1.2.4 Single-molecule Real-time Sequencing
  • 1.2.5 Nanopore Sequencing
• 1.3 Market by Application
  • 1.3.1 Global NGS-based RNA-sequencing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Research & Academia
  • 1.3.3 Hospitals & Clinics
  • 1.3.4 Pharmaceutical & Biotechnology Companies
  • 1.3.5 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global NGS-based RNA-sequencing Market Perspective (2017-2028)
• 2.2 NGS-based RNA-sequencing Growth Trends by Region
  • 2.2.1 NGS-based RNA-sequencing Market Size by Region: 2017 VS 2021 VS 2028
  • 2.2.2 NGS-based RNA-sequencing Historic Market Size by Region (2017-2022)
  • 2.2.3 NGS-based RNA-sequencing Forecasted Market Size by Region (2023-2028)
• 2.3 NGS-based RNA-sequencing Market Dynamics
  • 2.3.1 NGS-based RNA-sequencing Industry Trends
  • 2.3.2 NGS-based RNA-sequencing Market Drivers
  • 2.3.3 NGS-based RNA-sequencing Market Challenges
  • 2.3.4 NGS-based RNA-sequencing Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top NGS-based RNA-sequencing Players by Revenue
  • 3.1.1 Global Top NGS-based RNA-sequencing Players by Revenue (2017-2022)
  • 3.1.2 Global NGS-based RNA-sequencing Revenue Market Share by Players (2017-2022)
• 3.2 Global NGS-based RNA-sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Players Covered: Ranking by NGS-based RNA-sequencing Revenue
• 3.4 Global NGS-based RNA-sequencing Market Concentration Ratio
  • 3.4.1 Global NGS-based RNA-sequencing Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by NGS-based RNA-sequencing Revenue in 2021
• 3.5 NGS-based RNA-sequencing Key Players Head office and Area Served
• 3.6 Key Players NGS-based RNA-sequencing Product Solution and Service
• 3.7 Date of Enter into NGS-based RNA-sequencing Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 NGS-based RNA-sequencing Breakdown Data by Type

• 4.1 Global NGS-based RNA-sequencing Historic Market Size by Type (2017-2022)
• 4.2 Global NGS-based RNA-sequencing Forecasted Market Size by Type (2023-2028)

5 NGS-based RNA-sequencing Breakdown Data by Application

• 5.1 Global NGS-based RNA-sequencing Historic Market Size by Application (2017-2022)
• 5.2 Global NGS-based RNA-sequencing Forecasted Market Size by Application (2023-2028)

6 North America

• 6.1 North America NGS-based RNA-sequencing Market Size (2017-2028)
• 6.2 North America NGS-based RNA-sequencing Market Size by Type
  • 6.2.1 North America NGS-based RNA-sequencing Market Size by Type (2017-2022)
  • 6.2.2 North America NGS-based RNA-sequencing Market Size by Type (2023-2028)
  • 6.2.3 North America NGS-based RNA-sequencing Market Share by Type (2017-2028)
• 6.3 North America NGS-based RNA-sequencing Market Size by Application
  • 6.3.1 North America NGS-based RNA-sequencing Market Size by Application (2017-2022)
  • 6.3.2 North America NGS-based RNA-sequencing Market Size by Application (2023-2028)
  • 6.3.3 North America NGS-based RNA-sequencing Market Share by Application (2017-2028)
• 6.4 North America NGS-based RNA-sequencing Market Size by Country
  • 6.4.1 North America NGS-based RNA-sequencing Market Size by Country (2017-2022)
  • 6.4.2 North America NGS-based RNA-sequencing Market Size by Country (2023-2028)
  • 6.4.3 U.S.
  • 6.4.4 Canada

7 Europe

• 7.1 Europe NGS-based RNA-sequencing Market Size (2017-2028)
• 7.2 Europe NGS-based RNA-sequencing Market Size by Type
  • 7.2.1 Europe NGS-based RNA-sequencing Market Size by Type (2017-2022)
  • 7.2.2 Europe NGS-based RNA-sequencing Market Size by Type (2023-2028)
  • 7.2.3 Europe NGS-based RNA-sequencing Market Share by Type (2017-2028)
• 7.3 Europe NGS-based RNA-sequencing Market Size by Application
  • 7.3.1 Europe NGS-based RNA-sequencing Market Size by Application (2017-2022)
  • 7.3.2 Europe NGS-based RNA-sequencing Market Size by Application (2023-2028)
  • 7.3.3 Europe NGS-based RNA-sequencing Market Share by Application (2017-2028)
• 7.4 Europe NGS-based RNA-sequencing Market Size by Country
  • 7.4.1 Europe NGS-based RNA-sequencing Market Size by Country (2017-2022)
  • 7.4.2 Europe NGS-based RNA-sequencing Market Size by Country (2023-2028)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic Countries

8 Asia-Pacific

• 8.1 Asia-Pacific NGS-based RNA-sequencing Market Size (2017-2028)
• 8.2 Asia-Pacific NGS-based RNA-sequencing Market Size by Type
  • 8.2.1 Asia-Pacific NGS-based RNA-sequencing Market Size by Type (2017-2022)
  • 8.2.2 Asia-Pacific NGS-based RNA-sequencing Market Size by Type (2023-2028)
  • 8.2.3 Asia-Pacific NGS-based RNA-sequencing Market Share by Type (2017-2028)
• 8.3 Asia-Pacific NGS-based RNA-sequencing Market Size by Application
  • 8.3.1 Asia-Pacific NGS-based RNA-sequencing Market Size by Application (2017-2022)
  • 8.3.2 Asia-Pacific NGS-based RNA-sequencing Market Size by Application (2023-2028)
  • 8.3.3 Asia-Pacific NGS-based RNA-sequencing Market Share by Application (2017-2028)
• 8.4 Asia-Pacific NGS-based RNA-sequencing Market Size by Region
  • 8.4.1 Asia-Pacific NGS-based RNA-sequencing Market Size by Region (2017-2022)
  • 8.4.2 Asia-Pacific NGS-based RNA-sequencing Market Size by Region (2023-2028)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America NGS-based RNA-sequencing Market Size (2017-2028)
• 9.2 Latin America NGS-based RNA-sequencing Market Size by Type
  • 9.2.1 Latin America NGS-based RNA-sequencing Market Size by Type (2017-2022)
  • 9.2.2 Latin America NGS-based RNA-sequencing Market Size by Type (2023-2028)
  • 9.2.3 Latin America NGS-based RNA-sequencing Market Share by Type (2017-2028)
• 9.3 Latin America NGS-based RNA-sequencing Market Size by Application
  • 9.3.1 Latin America NGS-based RNA-sequencing Market Size by Application (2017-2022)
  • 9.3.2 Latin America NGS-based RNA-sequencing Market Size by Application (2023-2028)
  • 9.3.3 Latin America NGS-based RNA-sequencing Market Share by Application (2017-2028)
• 9.4 Latin America NGS-based RNA-sequencing Market Size by Country
  • 9.4.1 Latin America NGS-based RNA-sequencing Market Size by Country (2017-2022)
  • 9.4.2 Latin America NGS-based RNA-sequencing Market Size by Country (2023-2028)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa NGS-based RNA-sequencing Market Size (2017-2028)
• 10.2 Middle East & Africa NGS-based RNA-sequencing Market Size by Type
  • 10.2.1 Middle East & Africa NGS-based RNA-sequencing Market Size by Type (2017-2022)
  • 10.2.2 Middle East & Africa NGS-based RNA-sequencing Market Size by Type (2023-2028)
  • 10.2.3 Middle East & Africa NGS-based RNA-sequencing Market Share by Type (2017-2028)
• 10.3 Middle East & Africa NGS-based RNA-sequencing Market Size by Application
  • 10.3.1 Middle East & Africa NGS-based RNA-sequencing Market Size by Application (2017-2022)
  • 10.3.2 Middle East & Africa NGS-based RNA-sequencing Market Size by Application (2023-2028)
  • 10.3.3 Middle East & Africa NGS-based RNA-sequencing Market Share by Application (2017-2028)
• 10.4 Middle East & Africa NGS-based RNA-sequencing Market Size by Country
  • 10.4.1 Middle East & Africa NGS-based RNA-sequencing Market Size by Country (2017-2022)
  • 10.4.2 Middle East & Africa NGS-based RNA-sequencing Market Size by Country (2023-2028)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Illumina
  • 11.1.1 Illumina Company Details
  • 11.1.2 Illumina Business Overview
  • 11.1.3 Illumina NGS-based RNA-sequencing Introduction
  • 11.1.4 Illumina Revenue in NGS-based RNA-sequencing Business (2017-2022)
  • 11.1.5 Illumina Recent Developments
• 11.2 Thermo Fischer Scientific
  • 11.2.1 Thermo Fischer Scientific Company Details
  • 11.2.2 Thermo Fischer Scientific Business Overview
  • 11.2.3 Thermo Fischer Scientific NGS-based RNA-sequencing Introduction
  • 11.2.4 Thermo Fischer Scientific Revenue in NGS-based RNA-sequencing Business (2017-2022)
  • 11.2.5 Thermo Fischer Scientific Recent Developments
• 11.3 Oxford Nanopore
  • 11.3.1 Oxford Nanopore Company Details
  • 11.3.2 Oxford Nanopore Business Overview
  • 11.3.3 Oxford Nanopore NGS-based RNA-sequencing Introduction
  • 11.3.4 Oxford Nanopore Revenue in NGS-based RNA-sequencing Business (2017-2022)
  • 11.3.5 Oxford Nanopore Recent Developments
• 11.4 Agilent Technologies
  • 11.4.1 Agilent Technologies Company Details
  • 11.4.2 Agilent Technologies Business Overview
  • 11.4.3 Agilent Technologies NGS-based RNA-sequencing Introduction
  • 11.4.4 Agilent Technologies Revenue in NGS-based RNA-sequencing Business (2017-2022)
  • 11.4.5 Agilent Technologies Recent Developments
• 11.5 BGI
  • 11.5.1 BGI Company Details
  • 11.5.2 BGI Business Overview
  • 11.5.3 BGI NGS-based RNA-sequencing Introduction
  • 11.5.4 BGI Revenue in NGS-based RNA-sequencing Business (2017-2022)
  • 11.5.5 BGI Recent Developments
• 11.6 PerkinElmer
  • 11.6.1 PerkinElmer Company Details
  • 11.6.2 PerkinElmer Business Overview
  • 11.6.3 PerkinElmer NGS-based RNA-sequencing Introduction
  • 11.6.4 PerkinElmer Revenue in NGS-based RNA-sequencing Business (2017-2022)
  • 11.6.5 PerkinElmer Recent Developments
• 11.7 QIAGEN
  • 11.7.1 QIAGEN Company Details
  • 11.7.2 QIAGEN Business Overview
  • 11.7.3 QIAGEN NGS-based RNA-sequencing Introduction
  • 11.7.4 QIAGEN Revenue in NGS-based RNA-sequencing Business (2017-2022)
  • 11.7.5 QIAGEN Recent Developments
• 11.8 Eurofins Scientific
  • 11.8.1 Eurofins Scientific Company Details
  • 11.8.2 Eurofins Scientific Business Overview
  • 11.8.3 Eurofins Scientific NGS-based RNA-sequencing Introduction
  • 11.8.4 Eurofins Scientific Revenue in NGS-based RNA-sequencing Business (2017-2022)
  • 11.8.5 Eurofins Scientific Recent Developments
• 11.9 Roche
  • 11.9.1 Roche Company Details
  • 11.9.2 Roche Business Overview
  • 11.9.3 Roche NGS-based RNA-sequencing Introduction
  • 11.9.4 Roche Revenue in NGS-based RNA-sequencing Business (2017-2022)
  • 11.9.5 Roche Recent Developments
• 11.10 Takara Bio
  • 11.10.1 Takara Bio Company Details
  • 11.10.2 Takara Bio Business Overview
  • 11.10.3 Takara Bio NGS-based RNA-sequencing Introduction
  • 11.10.4 Takara Bio Revenue in NGS-based RNA-sequencing Business (2017-2022)
  • 11.10.5 Takara Bio Recent Developments
• 11.11 GENEWIZ
  • 11.11.1 GENEWIZ Company Details
  • 11.11.2 GENEWIZ Business Overview
  • 11.11.3 GENEWIZ NGS-based RNA-sequencing Introduction
  • 11.11.4 GENEWIZ Revenue in NGS-based RNA-sequencing Business (2017-2022)
  • 11.11.5 GENEWIZ Recent Developments
• 11.12 Hamilton
  • 11.12.1 Hamilton Company Details
  • 11.12.2 Hamilton Business Overview
  • 11.12.3 Hamilton NGS-based RNA-sequencing Introduction
  • 11.12.4 Hamilton Revenue in NGS-based RNA-sequencing Business (2017-2022)
  • 11.12.5 Hamilton Recent Developments
• 11.13 Macrogen
  • 11.13.1 Macrogen Company Details
  • 11.13.2 Macrogen Business Overview
  • 11.13.3 Macrogen NGS-based RNA-sequencing Introduction
  • 11.13.4 Macrogen Revenue in NGS-based RNA-sequencing Business (2017-2022)
  • 11.13.5 Macrogen Recent Developments
• 11.14 Zymo Research
  • 11.14.1 Zymo Research Company Details
  • 11.14.2 Zymo Research Business Overview
  • 11.14.3 Zymo Research NGS-based RNA-sequencing Introduction
  • 11.14.4 Zymo Research Revenue in NGS-based RNA-sequencing Business (2017-2022)
  • 11.14.5 Zymo Research Recent Developments
• 11.15 Tecan Genomics
  • 11.15.1 Tecan Genomics Company Details
  • 11.15.2 Tecan Genomics Business Overview
  • 11.15.3 Tecan Genomics NGS-based RNA-sequencing Introduction
  • 11.15.4 Tecan Genomics Revenue in NGS-based RNA-sequencing Business (2017-2022)
  • 11.15.5 Tecan Genomics Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Author Details
• 13.3 Disclaimer

• Table 1. Global NGS-based RNA-sequencing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
• Table 2. Key Players of Sequencing by Synthesis
• Table 3. Key Players of Ion Semiconductor Sequencing
• Table 4. Key Players of Single-molecule Real-time Sequencing
• Table 5. Key Players of Nanopore Sequencing
• Table 6. Global NGS-based RNA-sequencing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
• Table 7. Global NGS-based RNA-sequencing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
• Table 8. Global NGS-based RNA-sequencing Market Size by Region (2017-2022) & (US$ Million)
• Table 9. Global NGS-based RNA-sequencing Market Share by Region (2017-2022)
• Table 10. Global NGS-based RNA-sequencing Forecasted Market Size by Region (2023-2028) & (US$ Million)
• Table 11. Global NGS-based RNA-sequencing Market Share by Region (2023-2028)
• Table 12. NGS-based RNA-sequencing Market Trends
• Table 13. NGS-based RNA-sequencing Market Drivers
• Table 14. NGS-based RNA-sequencing Market Challenges
• Table 15. NGS-based RNA-sequencing Market Restraints
• Table 16. Global NGS-based RNA-sequencing Revenue by Players (2017-2022) & (US$ Million)
• Table 17. Global NGS-based RNA-sequencing Revenue Share by Players (2017-2022)
• Table 18. Global Top NGS-based RNA-sequencing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS-based RNA-sequencing as of 2021)
• Table 19. Ranking of Global Top NGS-based RNA-sequencing Companies by Revenue (US$ Million) in 2021
• Table 20. Global 5 Largest Players Market Share by NGS-based RNA-sequencing Revenue (CR5 and HHI) & (2017-2022)
• Table 21. Key Players Headquarters and Area Served
• Table 22. Key Players NGS-based RNA-sequencing Product Solution and Service
• Table 23. Date of Enter into NGS-based RNA-sequencing Market
• Table 24. Mergers & Acquisitions, Expansion Plans
• Table 25. Global NGS-based RNA-sequencing Market Size by Type (2017-2022) & (US$ Million)
• Table 26. Global NGS-based RNA-sequencing Revenue Market Share by Type (2017-2022)
• Table 27. Global NGS-based RNA-sequencing Forecasted Market Size by Type (2023-2028) & (US$ Million)
• Table 28. Global NGS-based RNA-sequencing Revenue Market Share by Type (2023-2028)
• Table 29. Global NGS-based RNA-sequencing Market Size by Application (2017-2022) & (US$ Million)
• Table 30. Global NGS-based RNA-sequencing Revenue Share by Application (2017-2022)
• Table 31. Global NGS-based RNA-sequencing Forecasted Market Size by Application (2023-2028) & (US$ Million)
• Table 32. Global NGS-based RNA-sequencing Revenue Share by Application (2023-2028)
• Table 33. North America NGS-based RNA-sequencing Market Size by Type (2017-2022) & (US$ Million)
• Table 34. North America NGS-based RNA-sequencing Market Size by Type (2023-2028) & (US$ Million)
• Table 35. North America NGS-based RNA-sequencing Market Size by Application (2017-2022) & (US$ Million)
• Table 36. North America NGS-based RNA-sequencing Market Size by Application (2023-2028) & (US$ Million)
• Table 37. North America NGS-based RNA-sequencing Market Size by Country (2017-2022) & (US$ Million)
• Table 38. North America NGS-based RNA-sequencing Market Size by Country (2023-2028) & (US$ Million)
• Table 39. Europe NGS-based RNA-sequencing Market Size by Type (2017-2022) & (US$ Million)
• Table 40. Europe NGS-based RNA-sequencing Market Size by Type (2023-2028) & (US$ Million)
• Table 41. Europe NGS-based RNA-sequencing Market Size by Application (2017-2022) & (US$ Million)
• Table 42. Europe NGS-based RNA-sequencing Market Size by Application (2023-2028) & (US$ Million)
• Table 43. Europe NGS-based RNA-sequencing Market Size by Country (2017-2022) & (US$ Million)
• Table 44. Europe NGS-based RNA-sequencing Market Size by Country (2023-2028) & (US$ Million)
• Table 45. Asia Pacific NGS-based RNA-sequencing Market Size by Type (2017-2022) & (US$ Million)
• Table 46. Asia Pacific NGS-based RNA-sequencing Market Size by Type (2023-2028) & (US$ Million)
• Table 47. Asia Pacific NGS-based RNA-sequencing Market Size by Application (2017-2022) & (US$ Million)
• Table 48. Asia Pacific NGS-based RNA-sequencing Market Size by Application (2023-2028) & (US$ Million)
• Table 49. Asia Pacific NGS-based RNA-sequencing Market Size by Region (2017-2022) & (US$ Million)
• Table 50. Asia Pacific NGS-based RNA-sequencing Market Size by Region (2023-2028) & (US$ Million)
• Table 51. Latin America NGS-based RNA-sequencing Market Size by Type (2017-2022) & (US$ Million)
• Table 52. Latin America NGS-based RNA-sequencing Market Size by Type (2023-2028) & (US$ Million)
• Table 53. Latin America NGS-based RNA-sequencing Market Size by Application (2017-2022) & (US$ Million)
• Table 54. Latin America NGS-based RNA-sequencing Market Size by Application (2023-2028) & (US$ Million)
• Table 55. Latin America NGS-based RNA-sequencing Market Size by Country (2017-2022) & (US$ Million)
• Table 56. Latin America NGS-based RNA-sequencing Market Size by Country (2023-2028) & (US$ Million)
• Table 57. Middle East and Africa NGS-based RNA-sequencing Market Size by Type (2017-2022) & (US$ Million)
• Table 58. Middle East and Africa NGS-based RNA-sequencing Market Size by Type (2023-2028) & (US$ Million)
• Table 59. Middle East and Africa NGS-based RNA-sequencing Market Size by Application (2017-2022) & (US$ Million)
• Table 60. Middle East and Africa NGS-based RNA-sequencing Market Size by Application (2023-2028) & (US$ Million)
• Table 61. Middle East and Africa NGS-based RNA-sequencing Market Size by Country (2017-2022) & (US$ Million)
• Table 62. Middle East and Africa NGS-based RNA-sequencing Market Size by Country (2023-2028) & (US$ Million)
• Table 63. Illumina Company Details
• Table 64. Illumina Business Overview
• Table 65. Illumina NGS-based RNA-sequencing Product
• Table 66. Illumina Revenue in NGS-based RNA-sequencing Business (2017-2022) & (US$ Million)
• Table 67. Illumina Recent Developments
• Table 68. Thermo Fischer Scientific Company Details
• Table 69. Thermo Fischer Scientific Business Overview
• Table 70. Thermo Fischer Scientific NGS-based RNA-sequencing Product
• Table 71. Thermo Fischer Scientific Revenue in NGS-based RNA-sequencing Business (2017-2022) & (US$ Million)
• Table 72. Thermo Fischer Scientific Recent Developments
• Table 73. Oxford Nanopore Company Details
• Table 74. Oxford Nanopore Business Overview
• Table 75. Oxford Nanopore NGS-based RNA-sequencing Product
• Table 76. Oxford Nanopore Revenue in NGS-based RNA-sequencing Business (2017-2022) & (US$ Million)
• Table 77. Oxford Nanopore Recent Developments
• Table 78. Agilent Technologies Company Details
• Table 79. Agilent Technologies Business Overview
• Table 80. Agilent Technologies NGS-based RNA-sequencing Product
• Table 81. Agilent Technologies Revenue in NGS-based RNA-sequencing Business (2017-2022) & (US$ Million)
• Table 82. Agilent Technologies Recent Developments
• Table 83. BGI Company Details
• Table 84. BGI Business Overview
• Table 85. BGI NGS-based RNA-sequencing Product
• Table 86. BGI Revenue in NGS-based RNA-sequencing Business (2017-2022) & (US$ Million)
• Table 87. BGI Recent Developments
• Table 88. PerkinElmer Company Details
• Table 89. PerkinElmer Business Overview
• Table 90. PerkinElmer NGS-based RNA-sequencing Product
• Table 91. PerkinElmer Revenue in NGS-based RNA-sequencing Business (2017-2022) & (US$ Million)
• Table 92. PerkinElmer Recent Developments
• Table 93. QIAGEN Company Details
• Table 94. QIAGEN Business Overview
• Table 95. QIAGEN NGS-based RNA-sequencing Product
• Table 96. QIAGEN Revenue in NGS-based RNA-sequencing Business (2017-2022) & (US$ Million)
• Table 97. QIAGEN Recent Developments
• Table 98. Eurofins Scientific Company Details
• Table 99. Eurofins Scientific Business Overview
• Table 100. Eurofins Scientific NGS-based RNA-sequencing Product
• Table 101. Eurofins Scientific Revenue in NGS-based RNA-sequencing Business (2017-2022) & (US$ Million)
• Table 102. Eurofins Scientific Recent Developments
• Table 103. Roche Company Details
• Table 104. Roche Business Overview
• Table 105. Roche NGS-based RNA-sequencing Product
• Table 106. Roche Revenue in NGS-based RNA-sequencing Business (2017-2022) & (US$ Million)
• Table 107. Roche Recent Developments
• Table 108. Takara Bio Company Details
• Table 109. Takara Bio Business Overview
• Table 110. Takara Bio NGS-based RNA-sequencing Product
• Table 111. Takara Bio Revenue in NGS-based RNA-sequencing Business (2017-2022) & (US$ Million)
• Table 112. Takara Bio Recent Developments
• Table 113. GENEWIZ Company Details
• Table 114. GENEWIZ Business Overview
• Table 115. GENEWIZ NGS-based RNA-sequencing Product
• Table 116. GENEWIZ Revenue in NGS-based RNA-sequencing Business (2017-2022) & (US$ Million)
• Table 117. GENEWIZ Recent Developments
• Table 118. Hamilton Company Details
• Table 119. Hamilton Business Overview
• Table 120. Hamilton NGS-based RNA-sequencing Product
• Table 121. Hamilton Revenue in NGS-based RNA-sequencing Business (2017-2022) & (US$ Million)
• Table 122. Hamilton Recent Developments
• Table 123. Macrogen Company Details
• Table 124. Macrogen Business Overview
• Table 125. Macrogen NGS-based RNA-sequencing Product
• Table 126. Macrogen Revenue in NGS-based RNA-sequencing Business (2017-2022) & (US$ Million)
• Table 127. Macrogen Recent Developments
• Table 128. Zymo Research Company Details
• Table 129. Zymo Research Business Overview
• Table 130. Zymo Research NGS-based RNA-sequencing Product
• Table 131. Zymo Research Revenue in NGS-based RNA-sequencing Business (2017-2022) & (US$ Million)
• Table 132. Zymo Research Recent Developments
• Table 133. Tecan Genomics Company Details
• Table 134. Tecan Genomics Business Overview
• Table 135. Tecan Genomics NGS-based RNA-sequencing Product
• Table 136. Tecan Genomics Revenue in NGS-based RNA-sequencing Business (2017-2022) & (US$ Million)
• Table 137. Tecan Genomics Recent Developments
• Table 138. Research Programs/Design for This Report
• Table 139. Key Data Information from Secondary Sources
• Table 140. Key Data Information from Primary Sources

List of Figures

• Figure 1. Global NGS-based RNA-sequencing Market Share by Type: 2021 VS 2028
• Figure 2. Sequencing by Synthesis Features
• Figure 3. Ion Semiconductor Sequencing Features
• Figure 4. Single-molecule Real-time Sequencing Features
• Figure 5. Nanopore Sequencing Features
• Figure 6. Global NGS-based RNA-sequencing Market Share by Application: 2021 VS 2028
• Figure 7. Research & Academia Case Studies
• Figure 8. Hospitals & Clinics Case Studies
• Figure 9. Pharmaceutical & Biotechnology Companies Case Studies
• Figure 10. Others Case Studies
• Figure 11. NGS-based RNA-sequencing Report Years Considered
• Figure 12. Global NGS-based RNA-sequencing Market Size (US$ Million), Year-over-Year: 2017-2028
• Figure 13. Global NGS-based RNA-sequencing Market Size, (US$ Million), 2017 VS 2021 VS 2028
• Figure 14. Global NGS-based RNA-sequencing Market Share by Region: 2021 VS 2028
• Figure 15. Global NGS-based RNA-sequencing Market Share by Players in 2021
• Figure 16. Global Top NGS-based RNA-sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS-based RNA-sequencing as of 2021)
• Figure 17. The Top 10 and 5 Players Market Share by NGS-based RNA-sequencing Revenue in 2021
• Figure 18. North America NGS-based RNA-sequencing Market Size YoY (2017-2028) & (US$ Million)
• Figure 19. North America NGS-based RNA-sequencing Market Size Market Share by Type (2017-2028)
• Figure 20. North America NGS-based RNA-sequencing Market Size Market Share by Application (2017-2028)
• Figure 21. North America NGS-based RNA-sequencing Market Size Share by Country (2017-2028)
• Figure 22. United States NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 23. Canada NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 24. Europe NGS-based RNA-sequencing Market Size YoY (2017-2028) & (US$ Million)
• Figure 25. Europe NGS-based RNA-sequencing Market Size Market Share by Type (2017-2028)
• Figure 26. Europe NGS-based RNA-sequencing Market Size Market Share by Application (2017-2028)
• Figure 27. Europe NGS-based RNA-sequencing Market Size Share by Country (2017-2028)
• Figure 28. Germany NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 29. France NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 30. U.K. NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 31. Italy NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 32. Russia NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 33. Nordic Countries NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 34. Asia-Pacific NGS-based RNA-sequencing Market Size YoY (2017-2028) & (US$ Million)
• Figure 35. Asia Pacific NGS-based RNA-sequencing Market Size Market Share by Type (2017-2028)
• Figure 36. Asia Pacific NGS-based RNA-sequencing Market Size Market Share by Application (2017-2028)
• Figure 37. Asia Pacific NGS-based RNA-sequencing Market Size Share by Region (2017-2028)
• Figure 38. China NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 39. Japan NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 40. South Korea NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 41. Southeast Asia NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 42. India NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 43. Australia NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

• Figure 44. Latin America NGS-based RNA-sequencing Market Size YoY (2017-2028) & (US$ Million)
• Figure 45. Latin America NGS-based RNA-sequencing Market Size Market Share by Type (2017-2028)
• Figure 46. Latin America NGS-based RNA-sequencing Market Size Market Share by Application (2017-2028)
• Figure 47. Latin America NGS-based RNA-sequencing Market Size Share by Country (2017-2028)
• Figure 48. Mexico NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 49. Brazil NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 50. Middle East & Africa NGS-based RNA-sequencing Market Size YoY (2017-2028) & (US$ Million)
• Figure 51. Middle East and Africa NGS-based RNA-sequencing Market Size Market Share by Type (2017-2028)
• Figure 52. Middle East and Africa NGS-based RNA-sequencing Market Size Market Share by Application (2017-2028)
• Figure 53. Middle East and Africa NGS-based RNA-sequencing Market Size Share by Country (2017-2028)
• Figure 54. Turkey NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 55. Saudi Arabia NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 56. UAE NGS-based RNA-sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 57. Illumina Revenue Growth Rate in NGS-based RNA-sequencing Business (2017-2022)
• Figure 58. Thermo Fischer Scientific Revenue Growth Rate in NGS-based RNA-sequencing Business (2017-2022)
• Figure 59. Oxford Nanopore Revenue Growth Rate in NGS-based RNA-sequencing Business (2017-2022)
• Figure 60. Agilent Technologies Revenue Growth Rate in NGS-based RNA-sequencing Business (2017-2022)
• Figure 61. BGI Revenue Growth Rate in NGS-based RNA-sequencing Business (2017-2022)
• Figure 62. PerkinElmer Revenue Growth Rate in NGS-based RNA-sequencing Business (2017-2022)
• Figure 63. QIAGEN Revenue Growth Rate in NGS-based RNA-sequencing Business (2017-2022)
• Figure 64. Eurofins Scientific Revenue Growth Rate in NGS-based RNA-sequencing Business (2017-2022)
• Figure 65. Roche Revenue Growth Rate in NGS-based RNA-sequencing Business (2017-2022)
• Figure 66. Takara Bio Revenue Growth Rate in NGS-based RNA-sequencing Business (2017-2022)
• Figure 67. GENEWIZ Revenue Growth Rate in NGS-based RNA-sequencing Business (2017-2022)
• Figure 68. Hamilton Revenue Growth Rate in NGS-based RNA-sequencing Business (2017-2022)
• Figure 69. Macrogen Revenue Growth Rate in NGS-based RNA-sequencing Business (2017-2022)
• Figure 70. Zymo Research Revenue Growth Rate in NGS-based RNA-sequencing Business (2017-2022)
• Figure 71. Tecan Genomics Revenue Growth Rate in NGS-based RNA-sequencing Business (2017-2022)
• Figure 72. Bottom-up and Top-down Approaches for This Report
• Figure 73. Data Triangulation
• Figure 74. Key Executives Interviewed